![Steven Chan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Chan
Directeur Financier/CFO chez
ATTOVIA THERAPEUTICS, INC.
Fortune : 22 000 $ au 31/08/2026
Profil
Steven Chan is currently Chief Financial Officer at Suzhou Connect Biopharma Co. Ltd. and Chief Financial Officer at Attovia Therapeutics, Inc. Former roles include Chief Financial Officer at Connect Biopharma Holdings Ltd. (2021–2024), Chief Financial Officer at Delphon Industries LLC (2019–2021), Vice President-Finance & Controller at Arcus Biosciences, Inc. (2017–2019), Chief Accounting Officer, VP & Controller at MyoKardia, Inc. (2016–2017), Vice President & Controller at Solta Medical, Inc. (2010–2014), Vice President-Finance at Moody's Analytics, Inc. (2007–2010), Director-Worldwide Revenue at Polycom, Inc. (2006–2007), Controller at Logitech International SA (2002–2006).
Education includes undergraduate studies at Haas School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/03/2025 | 10 000 ( 0,02 % ) | 22 000 $ | 31/08/2026 |
Postes actifs de Steven Chan
| Sociétés | Poste | Début |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Directeur Financier/CFO | 01/10/2024 |
Suzhou Connect Biopharma Co. Ltd.
 Suzhou Connect Biopharma Co. Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops innovative therapies that treat inflammatory diseases | Directeur Financier/CFO | - |
Anciens postes connus de Steven Chan
| Sociétés | Poste | Fin |
|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Directeur Financier/CFO | 13/09/2024 |
Delphon Industries LLC
 Delphon Industries LLC Industrial SpecialtiesProcess Industries Develops and manufactures packaging materials and adhesive tapes | Directeur Financier/CFO | 01/11/2021 |
| ARCUS BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 01/04/2019 |
| MYOKARDIA, INC. | Directeur Financier/CFO | 01/01/2016 |
Solta Medical, Inc.
 Solta Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes aesthetics technologies for skin tightening | Comptroller/Controller/Auditor | 01/07/2014 |
Formation de Steven Chan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Polycom, Inc.
 Polycom, Inc. Electronics/AppliancesConsumer Durables Provides solutions for video, voice, data and web communication | Consumer Durables |
Logitech International SA
 Logitech International SA Computer PeripheralsElectronic Technology Designs, manufactures and markets products which helps to connect people with digital and cloud experiences | Electronic Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Delphon Industries LLC
Delphon Industries LLC Industrial SpecialtiesProcess Industries Develops and manufactures packaging materials and adhesive tapes | Process Industries |
Moody's Analytics, Inc.
 Moody's Analytics, Inc. Miscellaneous Commercial ServicesCommercial Services Designs and delivers education on credit risk topics | Commercial Services |
Solta Medical, Inc.
Solta Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes aesthetics technologies for skin tightening | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Suzhou Connect Biopharma Co. Ltd.
Suzhou Connect Biopharma Co. Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops innovative therapies that treat inflammatory diseases | Health Technology |
Connect Biopharma Holdings Ltd.
 Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Attovia Therapeutics
 Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
